AI assistant
TALPHERA, INC. — Director's Dealing 2019
Feb 7, 2019
35181_dirs_2019-02-07_20c6e7b7-af7d-4c5c-989a-f76d063a626e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2018-12-31
Reporting Person: HOFFMAN STEPHEN J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-24 | Stock Option (Right to Buy) | $10.22 | A | 15000 | Acquired | 2024-07-23 | Common Stock (15000) | Direct |
| 2015-06-23 | Stock Option (Right to Buy) | $4.08 | A | 15000 | Acquired | 2025-06-22 | Common Stock (15000) | Direct |
| 2016-06-21 | Stock Option (Right to Buy) | $2.87 | A | 15000 | Acquired | 2026-06-20 | Common Stock (15000) | Direct |
| 2017-06-15 | Stock Option (Right to Buy) | $2.30 | A | 15000 | Acquired | 2027-06-14 | Common Stock (15000) | Direct |
| 2018-06-14 | Stock Option (Right to Buy) | $4.125 | A | 15000 | Acquired | 2028-06-14 | Common Stock (15000) | Direct |
Footnotes
F1: Issued pursuant to the 2011 Equity Incentive Plan.
F2: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer.
F3: Fully vested.
F4: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.
F5: 100% Acceleration upon Change of Control.